EUVIMEDEUVIMED entdecken
Crossref

Immune checkpoint inhibitor–related adverse events: Real-world experience from a single veterans’ affairs medical center

Samantha Benz, Katherine A Sherman, Constantin A Dasanu iD, Juliana Alvarez-Argote iD

Journal of Oncology Pharmacy Practice · 2024

DOI: 10.1177/10781552231184178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, 2024. Verfasst von Samantha Benz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Zablocki Veterans Affairs Medical Center, Medical College of Wisconsin, Milwaukee, WI, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune checkpoint inhibitors (ICIs) are antineoplastic agents associated with a multitude of immune-related adverse events (irAEs). Available data from clinical trials include highly selective patient populations which may limit their applicability to real-world clinical practice.

Methods

We present a retrospective cohort study of cancer patients treated with ICI therapy at the Zablocki VA Medical Center between 2014 and 2021. Information on demographics, cancer diagnosis, type of therapy, treatment duration, comorbidities, irAE type, and overall survival were collected.

Results

We identified 187 patients who received at least one dose of ICI. About half the patients experienced at least one irAE, the most common categories being fatigue, pulmonary, and endocrine irAEs. Approximately half of the irAEs were diagnosed within the first three months of starting ICI therapy, and 60.38% of those who experienced irAEs discontinued ICI therapy. Patients who experienced endocrine or intestinal irAEs had a significantly longer overall survival.

Conclusion

Immune-related complications due to ICI therapy are common and can frequently lead to treatment discontinuation in the real-world setting. Endocrine and intestinal irAEs may correlate with improved survival. The ICI-treated patients who received palliative radiation therapy to the bone had less irAEs, possibly due to immunogenic cell death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsHumansRetrospective StudiesMaleFemaleAgedMiddle AgedUnited StatesAged, 80 and overDrug-Related Side Effects and Adverse ReactionsHospitals, VeteransCohort Studies

Stichwörter der Autor:innen

Immune checkpoint inhibitorsimmune-related adverse eventsimmunotherapyreal-world data

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Zablocki Veterans Affairs Medical Center, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Department of Research Health, Zablocki Veterans Affairs Medical Center, Milwaukee, WI, USA.
  • Lucy Curci Cancer Center, Eisenhower Health, Rancho Mirage, CA, USA.
  • Department of Medical Oncology and Hematology, University of California in San Diego Health System, San Diego, CA, USA.
  • Division of Hematology-Oncology, Department of Medicine, Zablocki Veterans Affairs Medical Center, Medical College of Wisconsin, Milwaukee, WI, USA.

ORCID-Profile: Constantin A Dasanu, Juliana Alvarez-Argote

Zitieren

APA

Benz, S., Sherman, K. A., Dasanu, C. A., & Alvarez-Argote, J. (2024). Immune checkpoint inhibitor–related adverse events: Real-world experience from a single veterans’ affairs medical center. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552231184178

Vancouver

Benz S, Sherman KA, Dasanu CA, Alvarez-Argote J. Immune checkpoint inhibitor–related adverse events: Real-world experience from a single veterans’ affairs medical center. Journal of Oncology Pharmacy Practice. 2024. doi:10.1177/10781552231184178

BibTeX
@article{Benz2024,
  author = {Benz, Samantha and Sherman, Katherine A and Dasanu, Constantin A and Alvarez-Argote, Juliana},
  title = {Immune checkpoint inhibitor–related adverse events: Real-world experience from a single veterans’ affairs medical center},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2024},
  doi = {10.1177/10781552231184178}
}
Kostenlos starten →